An analytical sensitivity claim belongs to the tested sample preparation and matrix, rather than to diazepam testing in every specimen.
Study findings
The laboratory method combined magnetic solid-phase extraction with UPLC–tandem mass spectrometry to measure diazepam residues in aquatic products. Reported detection and quantification limits were 0.20 and 0.50 micrograms per kilogram. Spiked-matrix recoveries ranged from 89.3% to 119.7%, with relative standard deviations of 0.8% to 10.2% across the tested conditions.
What limits the conclusion
The method used a particular adsorbent, extraction procedure and external-standard quantification. Recovery above one hundred percent indicates positive bias or matrix-related analytical behavior to assess, rather than creation of drug. Food-matrix validation cannot automatically establish performance in postmortem blood, urine, hair or a differently prepared tissue.
Implications for case review
In an analytical challenge, compare matrix, calibration, extraction, identification criteria and uncertainty with the actual laboratory method. A published low detection limit does not establish the concentration in a particular case or determine biological effect. This study supplies a concrete method-development example and performance data. It cannot validate a different assay solely because both use mass spectrometry, and detection of a food residue alone does not demonstrate a human pharmacological exposure or impairment.
Source and related reading
Source: PMC12692274, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: A Bromazepam Stability Assay Separated Parent Drug From a Degradation Impurity.
Leave a Reply